Nutex Health Inc. (NUTX) stock
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3070% below fair value
$171.41−17.78 (-9.40%)
Close on Nov 12, 2026Market cap $1.17BP/E 7.3Yield –
Earnings
Nutex Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 4, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$217.60M
-15.5% on a year earlier
EPS, Q3 FY2026
$5.71
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Nutex Health's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 4, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026after the close | $217.60M | -15.5% | $5.71 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026during market hours | $210.80M | -13.6% | $9.38 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026during market hours | $216.50M | +2.2% | $6.52 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 5, 2026during market hours | $151.70M | -41.1% | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 18, 2025during market hours | $257.60M | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 14, 2025during market hours | $244.00M | +220.6% | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 13, 2025during market hours | $211.80M | +213.8% | $2.56 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 31, 2025during market hours | $257.60M | +269.6% | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024during market hours | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024during market hours | $76.10M | +29.2% | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024during market hours | $67.50M | +19.9% | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 28, 2024during market hours | $69.70M | +29.8% | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 9, 2023during market hours | $62.70M | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 9, 2023during market hours | $58.90M | +1.6% | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 15, 2023during market hours | $56.30M | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 2, 2023during market hours | $53.70M | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 22, 2022during market hours | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 22, 2022during market hours | $58.00M | – | -$0.03 | Release |
| Q1 FY2012ended Mar 31, 2012 | Apr 5, 2012during market hours | – | – | – | Filing |
| Q3 FY2011ended Sep 30, 2011 | Nov 17, 2011before the open | – | – | – | Filing |
| Q2 FY2011ended Jun 30, 2011 | Aug 17, 2011during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Nutex Health has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Nutex Health puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Nutex Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
See a number that looks wrong?